SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
SEC Accession No. 0001140361-23-014858
Filing Date
2023-03-30
Accepted
2023-03-30 16:48:25
Documents
16
Period of Report
2023-03-30

Document Format Files

Seq Description Document Type Size
1 PREM14A ny20006478x1_prem14a.htm PREM14A 8549809
2 EXHIBIT 107 ny20006478x1_ex107.htm EX-FILING FEES 14212
3 ny20006478x1_bargraph01.jpg GRAPHIC 169174
4 ny20006478x1_bargraph02.jpg GRAPHIC 163569
5 ny20006478x1_graphic01x2.jpg GRAPHIC 308469
6 ny20006478x1_graphic01x3.jpg GRAPHIC 279182
7 ny20006478x1_graphic02x1.jpg GRAPHIC 166260
8 ny20006478x1_graphic03.jpg GRAPHIC 35752
9 ny20006478x1_graphic04x1.jpg GRAPHIC 329745
10 ny20006478x1_graphic05x1.jpg GRAPHIC 203401
11 ny20006478x1_graphic06.jpg GRAPHIC 313708
12 ny20006478x1_graphic07.jpg GRAPHIC 91420
13 ny20006478x1_graphic08x3.jpg GRAPHIC 342125
14 ny20006478x1_graphic09.jpg GRAPHIC 4123
15 ny20006478x1_pc01.jpg GRAPHIC 841464
16 ny20006478x1_pc02.jpg GRAPHIC 763081
  Complete submission text file 0001140361-23-014858.txt   14087013
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: PREM14A | Act: 34 | File No.: 000-51173 | Film No.: 23781366
SIC: 2834 Pharmaceutical Preparations